Hopkinton-based drug discovery and research firm Caliper Life Sciences Inc. has received a notice of allowance from the U.S. Patent and Trademark Office for a new imaging method that allows researchers to track diseases in animals.
The new patent, which covers a method of in vivo, non-invasive imaging of light generated within mammals, allows Caliper to provide licensing rights to the method, and should encourage customers to also buy imaging systems from Caliper, the company said.
Some companies already use Caliper imaging methods with equipment from other manufacturers, Caliper said.
The non-invasive imaging uses light generated within a mammal to allow researchers to track happenings within that mammal at a molecular level, Caliper said.
The development enables drug developers to study the effects of new drug compounds earlier in the drug development process, reducing the time it takes to get new drugs up for sale, the company said.
